Meet us at ATTD!
The ATTD congress in Amsterdam is just around the corner and different members of the DCB team will be on-site. Meet us there to discuss our services, potential collaborations or just chat over a coffee!

DCB at ATTD 2025
The ATTD (Advanced Technologies & Treatments in Diabetes) congress is the leading international meeting point for all those involved and interested in diabetes technology. DCB is thrilled to participate in this prestigious event in Amsterdam fostering connections with like-minded enthusiasts dedicated to diabetes technology, innovation, and research.
We will be present with different members of our team from different divisions. Additionally, members of our Lived Experience Panel will also be attending. We are looking forward to attending insightful Scientific sessions, exploring new innovative solutions and above all: networking with, you!
Also, we are excited to participate in ATTD Ignite 2025, an exclusive platform designed to foster innovation and collaboration in diabetes technology. This event, taking place on March 19, 2025, from 09:00 to 13:00 in Hall C, provides a unique opportunity for startups and researchers to connect, share insights, and accelerate breakthroughs in diabetes care. Greta Ehlers, Business Scouting & Development at DCB, will be speaking in the session “Empowering Startups for Success” from 09:05 to 10:00, where key topics such as funding strategies, pitch refinement, and global expansion will be discussed. Don’t miss this opportunity to gain valuable insights and engage with industry experts!
If you are attending ATTD and are eager to learn more about our services, the Open Innovation Challenge, our main research areas, our community, or any other topics – please reach out to those attending and book a coffee slot. We look forward to connecting with you!

Unable to attend ATTD but curious about our services and activities? We would also be happy to schedule calls for after the conference to discuss potential collaborations. Feel free to reach out to individual members of our team.
Downloads
Book a coffee with us!
Hanne Ballhausen
Project Manager Innovation
Dr. Maren Schinz
Project Lead Insulin Activity
Ema Grabenweger
Innovation Manager
Stefanie Hossmann
Clinical
Simon Schwaighofer
Business Development
Dr. Martina Rothenbühler
Sientific Program Manager
Greta Ehlers
Business Development
More recent news
SNAQ Launches AI-Powered Glucose Prediction feature
SNAQ has introduced a groundbreaking AI-driven feature that predicts glucose responses before meals, revolutionizing...
DCB featured in Finanz und Wirtschaft – Health & Wealth 3/2025
Discover how DCB leads the way in diabetes technology through its innovative collaborations and community-focused...
DCB featured in Sonntagszeitung – Gesundheitsguide 12/2024
Dive into the latest edition of Sonntagszeitung Gesundheitsguide and find out why DCB is global leader in diabetes...


DCB Research AG
Freiburgstrasse 3
3010 Bern
Switzerland